ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 10 filers reported holding ACORDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,293,000 | -35.8% | 2,350,000 | 0.0% | 0.00% | – |
Q3 2020 | $2,013,000 | -1.0% | 2,350,000 | 0.0% | 0.00% | – |
Q2 2020 | $2,033,000 | -0.7% | 2,350,000 | 0.0% | 0.00% | – |
Q1 2020 | $2,047,000 | +15.9% | 2,350,000 | 0.0% | 0.00% | – |
Q4 2019 | $1,766,000 | -48.7% | 2,350,000 | -46.6% | 0.00% | – |
Q3 2019 | $3,443,000 | -21.4% | 4,400,000 | -14.6% | 0.00% | -100.0% |
Q2 2019 | $4,381,000 | -3.6% | 5,150,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $4,545,000 | +6.7% | 5,150,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $4,261,000 | -52.1% | 5,150,000 | -51.2% | 0.00% | 0.0% |
Q3 2018 | $8,904,000 | +15.9% | 10,550,000 | +32.7% | 0.00% | 0.0% |
Q2 2018 | $7,683,000 | +10.5% | 7,950,000 | +3.9% | 0.00% | 0.0% |
Q1 2018 | $6,953,000 | -11.1% | 7,650,000 | +12.5% | 0.00% | 0.0% |
Q4 2014 | $7,824,000 | -26.1% | 6,800,000 | -33.3% | 0.00% | 0.0% |
Q3 2014 | $10,583,000 | – | 10,200,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |